Paper ยท 26720728
Inherited Mutations in Women With Ovarian Carcinoma.
Norquist BM and 18 others. JAMA Oncol, 2016. Cited by 620 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Inherited Mutations in Women With Ovarian Carcinoma. Papers, record 26720728. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26720728
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Predisposition to Disease | Major topic |
| Germ-Line Mutation | Major topic |
| Ovarian Neoplasms | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| DNA Mutational Analysis | |
| Disease-Free Survival | |
| Female | |
| Humans | |
| Middle Aged | |
| Prognosis | |
| Proportional Hazards Models |
Source PubMed
Grants44
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U10 CA180868 | NCI NIH HHS | United States | U10CA180868 | PubMed and NIH | NIH RePORTER |
| P20 CA097943 | NCI NIH HHS | United States | P20CA097943 | PubMed and NIH | NIH RePORTER |
| RC2 HL102923 | NHLBI NIH HHS | United States | RC2HL102923 | PubMed and NIH | NIH RePORTER |
| UC2 HL102926 | NHLBI NIH HHS | United States | RC2HL102926 | PubMed and NIH | NIH RePORTER |
| UC2 HL103010 | NHLBI NIH HHS | United States | RC2HL103010 | PubMed and NIH | NIH RePORTER |
| 1 U10 CA180822 | NCI NIH HHS | United States | U10CA180822 | PubMed and NIH | NIH RePORTER |
| U24 CA114793 | NCI NIH HHS | United States | U24CA114793 | PubMed and NIH | NIH RePORTER |
| R01CA131965 | NCI NIH HHS | United States | R01CA131965 | PubMed and NIH | NIH RePORTER |
| RC2 HL102926 | NHLBI NIH HHS | United States | RC2HL102926 | PubMed and NIH | NIH RePORTER |
| U10 CA27469 | NCI NIH HHS | United States | R10CA027469 | PubMed and NIH | NIH RePORTER |
1 to 10 of 44
See all 44 grantsTrials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 26,720,286 | Germline Sequence Variants and Ovarian Cancer: Known-Knowns and Known-Unknowns. | https://conductscience.org/library/papers/26720286 |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,573,085 | Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. | Nat Struct Biol | 2001 | https://conductscience.org/library/papers/11573085 | PubMed |
| 2 | 24,240,112 | Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24240112 | PubMed |
| 3 | 12,732,733 | Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12732733 | PubMed |
| 4 | 14,576,434 | Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. | Science | 2003 | https://conductscience.org/library/papers/14576434 | PubMed |
| 5 | 16,510,331 | Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. | Lancet Oncol | 2006 | https://conductscience.org/library/papers/16510331 | PubMed |
| 6 | 17,033,622 | Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. | Nat Genet | 2006 | https://conductscience.org/library/papers/17033622 | PubMed |
| 7 | 17,200,668 | PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. | Nat Genet | 2007 | https://conductscience.org/library/papers/17200668 | PubMed |
| 8 | 17,311,302 | Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. | Hum Mutat | 2007 | https://conductscience.org/library/papers/17311302 | PubMed |
| 9 | 20,400,964 | Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. | Nat Genet | 2010 | https://conductscience.org/library/papers/20400964 | PubMed |
| 10 | 20,616,022 | Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20616022 | PubMed |
1 to 10 of 39
See all 39 referencesCited by406
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 620 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,921,539 | Correlation between BRCA mutational status and lymph node metastasis in advanced epithelial ovarian cancer: a retrospective study. | PeerJ | 2026 | https://conductscience.org/library/papers/42921539 | PubMed |
| 42,907,928 | From cytoreduction to precision oncology: evolution of ovarian cancer therapy. | J Ovarian Res | 2026 | https://conductscience.org/library/papers/42907928 | PubMed |
| 42,898,852 | Prevalence and spectrum of variants in homologous recombination repair genes in ovarian cancer in Latin America: a systematic review and meta-analysis. | AJOG Glob Rep | 2026 | https://conductscience.org/library/papers/42898852 | PubMed |
| 42,811,315 | Cold atmospheric plasma treated medium (PTM) induce antitumor effects in human ovarian cancer cells. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42811315 | PubMed |
| 42,795,002 | Ovarian Precancerous Lesions and Their Molecular Landscape: A Structured Scoping Review Focused on STIC and Related Precursors of Epithelial Ovarian Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42795002 | PubMed |
| 42,793,028 | G2/M Checkpoint Dependency in High-Grade Serous Tubo-Ovarian Carcinoma: Mechanisms and Therapeutic Implications. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42793028 | PubMed |
| 42,763,573 | Metastasis of Pancreatic Intraductal Oncocytic Papillary Neoplasm to the Ovaries. | Case Rep Gastrointest Med | 2026 | https://conductscience.org/library/papers/42763573 | PubMed |
| 42,693,633 | A Novel BRCA1 Pathogenic Variant in Tunisian Patient With High Grade Ovarian Cancer: Favorable Therapeutic Response to Olaparib. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/42693633 | PubMed |
| 42,683,025 | Clinical Benefit of Pembrolizumab in Lynch Syndrome-Associated Advanced Ovarian Cancer With Germline MSH6 Variant: A Case Report. | Clin Case Rep | 2026 | https://conductscience.org/library/papers/42683025 | PubMed |
| 42,560,169 | Using Polygenic Risk Scores to Refine Risk and Outcomes in High-grade Serous Ovarian Cancer in Australia. | Cancer Epidemiol Biomarkers Prev | 2026 | https://conductscience.org/library/papers/42560169 | PubMed |
1 to 10 of 406
See all 406 cited byGenes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABRAXAS1 | 84,142 | PubTator's text mining | https://conductscience.org/library/genes/84142 | NCBI Gene |
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| BARD1 | 580 | PubTator's text mining | https://conductscience.org/library/genes/580 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| BRIP1 | 83,990 | PubTator's text mining | https://conductscience.org/library/genes/83990 | NCBI Gene |
| CHEK2 | 11,200 | PubTator's text mining | https://conductscience.org/library/genes/11200 | NCBI Gene |
| MLH1 | 4,292 | PubTator's text mining | https://conductscience.org/library/genes/4292 | NCBI Gene |
| MRE11 | 4,361 | PubTator's text mining | https://conductscience.org/library/genes/4361 | NCBI Gene |
| MSH2 | 4,436 | PubTator's text mining | https://conductscience.org/library/genes/4436 | NCBI Gene |
1 to 10 of 20
See all 20 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26720728
GET https://conductscience.org/api/papers/v1/26720728/grants?page=2